Skip to content
★ Sign in to follow
JC

John C. Price

Chief Financial Officer
Assure Holdings Corp.Panacea Life Sciences Holdings, Inc.SCWorx Corp.MusclePharm Corp
Total declarations
9
Companies
4
▲ Purchases (2 ops.)
€114k
▼ Sales (1 ops.)
€15k

Latest filing published 22 Nov 2022 for Assure Holdings Corp., €39k.

Filing timeline

BuySale
John C. Price

Insider track record

Disclosed buys
2
Disclosed sells
1
Signal history

Closed purchases

Market purchases
2
Positive at T+90
0%
Median T+90
-22.9%

Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.

Purchases by company

Since each purchase

  • Filed 22 Nov 2022 · 1447 days ago · €39k
    -96.7%
    Entry US$154.80 · Close at T+365 US$5.15
  • Filed 01 Dec 2021 · 1803 days ago · €75k
    -93.7%
    Entry US$2,340.00 · Close at T+365 US$147.60

Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.

John C. Price: trading record in brief

This profile gathers the share dealings of John C. Price across 4 companies, led by SCWorx Corp., Assure Holdings Corp. and MusclePharm Corp. The record holds 9 filings, for trades running from 28 April 2015 to 18 November 2022.

In open-market terms, that means 2 purchases worth €114k on one side and 1 sale worth €15k on the other. Netting one side against the other leaves €100k of net buying. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. Besides market trades, the filings include 5 share grants. So far in 2022, the count stands at 1 purchase and no sales.

The newest entry dates from 22 November 2022: an open-market purchase of €39k, in Assure Holdings Corp. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 7 days. US insiders must file a Form 4 within two business days of a trade. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.

Companies and markets linked to John C. Price

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations9 total
  • ▲
    CFOExecutivesAssure Holdings Corp.
    40,628 USD36SEC
    67,713 shares@ US$0.6034.3% of flowCommon stockSEC:0001415889-22-011705:0
    Canonical exit: 16 Feb 2023 (T+90)
  • ▲
    CFOExecutivesAssure Holdings Corp.
    84,803 USD41SEC
    13,700 shares@ US$6.1965.7% of flowCommon stockSEC:0001415889-21-005615:0
    Canonical exit: 27 Feb 2022 (T+90)
  • ▼
    ExecutivesSCWorx Corp.
    16,150 USD10SEC
    5,000 shares@ US$3.23100.0% of flowCommon StockSEC:0001104659-19-072699:0
  • ◆
    DirectorExecutivesPanacea Life Sciences Holdings, Inc.
    0SEC
    100,000 shares0Common StockSEC:0001415889-19-001390:0
  • ◆
    CFOExecutivesSCWorx Corp.
    0SEC
    250,000 shares0Restricted Stock Units (common stock)SEC:0001144204-19-009174:0
  • ◆
    CFOExecutivesSCWorx Corp.
    0SEC
    37,500 shares0Restricted Stock Units (common stock)SEC:0001144204-19-009174:1
  • ◆
    CFOExecutivesSCWorx Corp.
    0SEC
    37,500 shares0Restricted Stock Units (common stock)SEC:0001144204-19-009174:2
  • ◆
    CFOExecutivesSCWorx Corp.
    0SEC
    75,000 shares0Restricted Stock Units (common stock)SEC:0001144204-19-009174:3
  • ●
    Chief Financial OfficerExecutivesMusclePharm Corp
    0SEC
    50,000 sharesRestricted Common StockSEC:0001144204-15-027765:0

9 of 9 declarations